A drug called Lucentis, made by Genetech, has proved effective at treating the wet form of age-related maculardegeneration, which can lead to blindness.
The disease is wet age-related maculardegeneration (wet AMD), in which blood vessels grow abnormally and leak into the centre of the retina, damaging sufferers' central vision.